期刊文献+

可溶性重组日本血吸虫26 kDa GST的优化表达 被引量:10

Optimizing expression of recombinant 26-kilodalton glutathione S-transferases of Schistosoma japonicum in Escherchia coli
下载PDF
导出
摘要 目的探讨在大肠杆菌中表达可溶性重组日本血吸虫谷胱甘肽S-转移酶(rSj26 GST)的优化条件。方法用含有Sj26基因的原核表达载体pGEX-3X转化大肠杆菌BL21(DE3),将影响可溶性rSj26 GST表达的4个因素,即温度、诱导剂IPTG浓度、诱导时细菌的密度和诱导时间进行正交设计,确定其优化表达条件并大量表达,采用谷胱甘肽亲和层析法纯化表达的蛋白,测定酶活性,通过Western blot鉴定免疫活性。结果正交设计的直观分析和方差分析结果显示:可溶性rSj26GST最佳表达条件为温度25℃,IPTG的浓度1 mmol/L,诱导前细菌的生长密度0.9,诱导表达时间8 h。可溶性rSj26 GST纯化的产量为16 mg/L,Western blot证实rSj26 GST具有良好免疫原性和免疫反应性。结论通过正交设计确定了可溶性rSj26 GST在大肠杆菌中表达的优化条件。 To explore the best expressing condition of the recombinant 26-kilodalton glutathione S-transferases of S. japonicum(rSj26 GST) in Escherchia coli (E. coli) and to analyse its characterization. E. coli BL21(DE3) was transformed with plasmid pGEX-3X. The best expressing condition of rSj26 GST was explored through orthogonal design which took growth temperature, IPTG concentration, culture density, incubation time as indices. The expressed products (rSj26 GST) proteins were purified from supernatant bacterial lysates by affinity chromatography using reduced glutathione resin. It can be detected using functional assays and immunological methods. The pure rSj26 GST with the activity of glutathione S-transferase, and it could be recognized by the sera of rabbit and mouse infected with S. japonica. The rabbit was vaccinated with rSj26 GST and the highest level of the anti-rSj26 GST antibody was 1 : 256 000. Western blot analysis showed that the anti- rSj26 GST antibody could recognize the antigen of adult worm of Schistosoma japonica. The best expressing condition of the recombinant 26- kilodahon glutathione S-transferases of S. japonicum (rSj26 GST) in E, coli was determined through orthogonal design.
出处 《中国人兽共患病学报》 CAS CSCD 北大核心 2006年第8期770-773,共4页 Chinese Journal of Zoonoses
关键词 日本血吸虫 日本血吸虫谷胱甘肽 S-转移酶 蛋白表达 正交设计 大肠杆菌 Schistosoma japonicum glutathione S-transferases recombinant antigen protein expression orthogonal design Escherchia coli
  • 相关文献

参考文献6

二级参考文献35

  • 1曾宪忠,易新元,曾宪芳,周金春.核酸疫苗Sj31BIN联合IL-12免疫抗日本血吸虫攻击感染的实验研究[J].湖南医科大学学报,2000,5(4):334-336. 被引量:7
  • 2林矫矫,田锷,傅志强,叶萍,石耀军,林邦发,施福恢.中国大陆株日本血吸虫23kD基因重组抗原的研究──重组的23kD抗原大亲水区多肽对小鼠的免疫试验[J].中国兽医科技,1995,25(8):20-21. 被引量:6
  • 3F.奥斯伯 颜子颖(译).精编分子生物学实验指南[M].北京:科学出版社,1998.141.
  • 4[1]Dalton JP, Mulcahy G.Parasite vaccines- a reality? [J] .Vet. Parasitol,2001,98(1~3):149~ 167.
  • 5[2]Naus CW, Kimani G,Ouma JH,et al.Development of antibody isotype responses to Schistosome mansoni in an immunologically naive immigrant population:influen ofinfection,infection duration and host age [J].Infect Immun,1999,67:3444 ~ 3451.
  • 6[3]Smythies LE,Betts X,Coulson PS et al.Kinetics and mechanism of effector focus formation in the lungs of mice vaccinated with irradiated cercariae of Schistosome mansoni[J].Parasite Immunol, 1996, 18(7) ,359 ~ 369.
  • 7[4]Dunne DW,Webster M,Smith P, et al. The isolation of a 22kDa band after SDS - PAGE of Schistosome Mansoni adult worms and its use to demonstrate that IgE responses against the antigen(s) it contains are associated with human resistance to reinfection [J]. Parasite Inmunol,1997,19(2) :79 ~ 89.
  • 8[5]Butterworth AE, Dunne DW, Fulford AJ, et al.Immunity and morbidity in Schistosome mansoni infection: quantitative aspects[J]. Am. J. Trop. Med.Hyg, 1996,55(5 Suppl), 109 ~ 115.
  • 9[6]Wilkins HA, Blumenthal UJ, Hagan P, et al. Resistance to reinfection after treatment of urinary Schistosomiasis [J] .Trans .R. Soc.Trop. Med, 1987(1),81.29~ 35.
  • 10[7]Dessein AJ, Begley M, Demeure C, et al. Human resistance to Schistosome mansoni is associated with IgG rectivity to a 37 - kDa larval surface antigen[J]. J. Immunol, 1988(8), 140,2727 ~ 2736.

共引文献14

同被引文献93

引证文献10

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部